Vendome Acquisition Corp I

This filing establishes the SPAC's capital structure, trust account, and governance framework at the start of its search period. Investors are now able to track the trust value ($10.00 per share initially), the redemption deadline (July 2027), and sponsor conduct (including insider lock-up and voting commitments). Any future business combination or extension will be measured against the baseline set in this IPO filing.

Establishes the SPAC's capital structure, trust value, redemption mechanics, dilution from founder shares and warrants, sponsor incentives, and timeline for finding a target. Sets the baseline for all future redemption calculations and deal progress tracking.

The acceleration request advances the sponsor’s capital-raising timeline toward a late-June 2025 listing event, establishing a new regulatory clock for the IPO phase without altering the underlying search period or shareholder redemption rights tied to the original S-1. Legal representation includes Paul Hastings LLP and DLA Piper LLP (US), with Vendome coordination noted through Scott LaPorta. The filing contains no target-specific disclosures, revenue projections, market size estimates, strategic partnerships, or litigation updates beyond standard securities distribution confirmations.

Establishes the final terms of the IPO: 20,000,000 units (plus up to 3,000,000 over-allotment) at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half warrant. Trust account to hold $200,000,000 from firm units plus over-allotment proceeds, with $10.00 per public share. Private placement of 2,648,000 warrants at $1.00 each to sponsor. Working capital release of ~$840,000. Deadline for business combination is 24 months from IPO consummation. The governance documents include standard SPAC redemption and extension provisions. The SPAC remains in searching status with no target identified.

Provides the final or near-final terms for the SPAC's IPO, including trust mechanics, redemption rights, sponsor compensation with significant dilution potential (founder shares at $0.0043 per share), anti-dilution conversion adjustments, warrant terms, and lock-up provisions. Investors need this to evaluate sponsor incentives, trust value protection, and the timeline for a business combination.

For investors monitoring redemption deadlines, trust value, and sponsor behavior, the disclosed Working Capital Convertible Note establishes a clear path for the Sponsor to convert borrowed capital into Class A ordinary shares, creating dilution that operates outside the preliminary net tangible book value tables and could impact per-share redemption economics if drawn and converted. The filing leaves the stated $10.37 trust/share and 2027-07-03 business combination deadline unchanged but confirms ongoing regulatory scrutiny and iterative amendment activity. Beyond compliance revisions to the warrant forum and the sponsor-linked convertible note mechanics, the document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, ongoing litigation, or personnel. Correspondence inquiries are routed to Gil Savir of Paul Hastings LLP at 770-878-2696.

Per the SEC Division of Corporation Finance, these comments do not alter the SPAC’s operational timeline or force an extension. The directive to detail Working Capital Convertible Note conversion mechanics directly informs how sponsor advances may dilute public shareholders upon a business combination, affecting redemption calculus and post-combination ownership. The warrant jurisdiction clarification adjusts legal remedy pathways without impacting cash positions or trust distributions. The letter was issued by the Office of Real Estate & Construction on June 20, 2025, following review of the Amendment No. 1 filed June 6, 2025, maintaining the current SEARCHING status while deferring registration statement effectiveness until revisions addressing prior May 12, 2025 comments are submitted. Inquiries are assigned to William Demarest (202-551-3432) and Jennifer Monick (202-551-3295) for financial statements, and Pearlyne Paulemon (202-551-8714) and Mary Beth Breslin (202-551-3625) for other matters.

Eliminating the $5,000,001 net tangible asset threshold modifies the redemption mechanics, potentially enabling higher shareholder exit rates without triggering a liquidity fallback condition. Clarifying domestic control removes immediate foreign ownership barriers but exposes future targets to mandatory regulatory screening; as the Registrant warns, government delays or prohibitions could extinguish warrant value and force SPAC liquidation. Stating that the intended target valuation of $500 million outpaces available IPO and private placement capital signals imminent reliance on external follow-on financing, which introduces execution uncertainty, third-party approval dependencies, and pro-rata dilution pressure for public shareholders prior to any merger closing. Adjustments to the founder share roster alter insider holding counts without shifting the sponsor’s aggregate voting authority.

This filing establishes the definitive IPO terms for a new SPAC with $200-$230 million trust capacity, a 24-month deadline to complete a business combination, and significant sponsor compensation (founder shares at ~$0.0043 per share, private warrants at $1.00 each). Investors should note the 20% founder share ownership, the anti-dilution conversion rights, the lack of a minimum redemption threshold, and the ability to amend the charter with a two-thirds vote. The prospectus details redemption mechanics, potential dilution, and conflicts of interest, which are critical for evaluating the SPAC's risk profile.

This regulatory correspondence delivers essential forward-looking parameters for investors tracking redemption floors, trust allocation, extension probabilities, and sponsor governance prior to the 2027-07-03 liquidation deadline. By mandating explicit disclosure of the $5,000,001 net tangible asset redemption barrier, the SEC ensures holders understand the precise threshold where their exit rights may be contractually suspended, directly shaping liquidity planning near the extension window. The explicit acknowledgment that pursuing $500 million enterprise value targets necessitates future equity or debt financing warns of anticipated post-IPO dilution that will compress per-share trust value and alter warrant moneyness well before any announcement. Requests to map out non-U.S. sponsor connections and model CFIUS-driven liquidation scenarios alert holders that cross-border target screening faces institutional friction, expanding the statistical probability of a failed search that would terminate public trading and extinguish warrant value entirely. Transparent reporting of 105,000 founder shares flowing to directors and Amy Wang clarifies sponsor-side equity compensation, enabling investors to weigh governance alignment and baseline dilution against public shareholder capital preservation.

The S-1 establishes the complete terms of the SPAC. It confirms a $150 million trust, standard $10.00 per-share redemption, and a deadline structure that includes an automatic six-month extension (without a shareholder vote) if a definitive merger agreement is signed within 18 months—an above-average flexibility that reduces early redemption risk. The sponsor's nominal cost ($0.0058 per founder share) and the absence of a target create typical dilution and conflict concerns.

What changed: Schedule 13G/A, a routine compliance exhibit updating beneficial ownership disclosure. The excerpt identifies Glazer Capital, LLC and Paul J. Glazer as reporting parties under filing identifier [0001076809-26-000057], but the text supplies zero share counts, ownership percentages, voting authority, or transaction timestamps. Why it matters: Because it functions solely as a post-acquisition or pre-deal holdings notification, the filing contains no directives or data that would impact the July 2027 expiration window, the stated trust account valuation, extension mechanisms, target search progression, or sponsor conduct protocols. Furthermore, per the published language, neither reporting party advances assertions regarding customer pipelines, revenue runrates, total addressable markets, corporate strategy, technology roadmaps, commercial alliances, active litigation, or executive succession.

What changed: 10-K Annual Report for Vendome Acquisition Corporation I (VNME), a blank-check SPAC searching for a business combination. The Company completed its IPO on July 3, 2025, raising $200,000,000 (20,000,000 units at $10.00 per unit). Simultaneously, it sold 2,648,000 private placement warrants for an additional $2,648,000. As of December 31, 2025, $200,000,000 was placed in the trust account, earning $4,032,946 in interest, resulting in a trust value of $204,032,946 as of year-end. The trust redemption value per share is $10.20. Total transaction costs were $2,105,782. The deadline to complete a business combination is 24 months from the IPO closing (July 3, 2027). Why it matters: This is the first annual report following the IPO, providing the base financial condition for investors tracking the trust value, redemption mechanics, and sponsor conduct. The report confirms the trust is funded above the $10.00 threshold at $10.20 per share due to interest income, and that the Club has 24 months (until July 3, 2027) to complete a deal. It details sponsor share structure (5,000,000 founder shares, 20% stake) and the agreements governing sponsor behavior, including that the sponsor has agreed to vote in favor of any business combination and not to propose amendments altering redemption rights without a redemption offer. The report also highlights a unique risk: because of the sponsor’s low cost basis ($0.005 per founder share), the sponsor can profit even if public shares lose value, creating a potential misalignment of incentives.

What changed: Routine compliance exhibit: SEC Schedule 13G beneficial ownership report for VNME filed by Meteora Capital, LLC. The excerpt identifies Meteora Capital, LLC as the reporting entity. It contains no disclosed share quantities, ownership percentages, transaction dates, or statements regarding redemption windows, trust account balances, extension mechanisms, business combination status, or sponsor conduct; therefore, no SPAC mechanics or investor timeline parameters are altered in this text. Why it matters: A Schedule 13G generally signals aggregate, non-controlling beneficial ownership crossing regulatory thresholds. Because the provided excerpt lacks all numerical disclosures, purpose-of-transaction language, and substantive corporate or financial claims, it does not independently impact capital structure, liquidity mechanics, or deal pursuit timelines. Any material information regarding strategy, partnerships, or personnel would reside in the omitted tables and exhibit pages not supplied here.

What changed: A Schedule 13G/A amendment filing submitted to the SEC by Barclays PLC to report changes in beneficial ownership of Vendome Acquisition Corp I securities. The provided excerpt lists only the filer name (Barclays PLC) and the SEC control number. It discloses no share quantities, percentage thresholds, transaction dates, or purchase prices attributed to Barclays PLC or any other entity. Consequently, the text contains no update to redemption mechanisms, the $10.37 trust balance per share, extension votes, business combination milestones, or sponsor conduct. Why it matters: Because the submission is a routine regulatory ownership disclosure, it does not modify the SPAC's $10.37-per-share trust environment, the 2027-07-03 liquidation deadline, or investor redemption options. With no position size, acquisition date, or pricing attributed to Barclays PLC or any counterpart, the filing introduces no material catalyst for deal progress, partnership formation, technological development, or litigation that would alter the current SEARCHING status or trigger sponsorship action.

What changed: Quarterly report (Form 10-Q) for Vendome Acquisition Corp I for the quarterly period ended September 30, 2025, the company's first periodic report since its IPO on July 3, 2025. Trust account value per share increased to $10.10 from the initial $10.00 per unit, with $202,068,698 in trust on $200,000,000 of proceeds, reflecting $2,068,698 of interest income. Net income of $1,820,558 was reported from trust interest, with $248,140 in formation and operating expenses. Founder shares were restructured: on March 25, 2025, 5,544,643 Class B shares were surrendered for cancellation; on May 25, 2025, 1,437,500 new founder shares were issued to the Sponsor for no consideration; and 750,000 shares were forfeited because the underwriter did not exercise the over-allotment option. An additional 75,000 founder shares were transferred to independent director nominees. The Sponsor borrowed $300,000 under an unsecured promissory note, which was repaid on July 22, 2025. A convertible working capital note of up to $840,000 was issued. No business combination has been announced; the deadline remains 24 months from the IPO (July 3, 2027). Why it matters: This filing provides the first post-IPO financial snapshot, confirming the trust account is earning interest and per-share value is slightly above $10.00. The founder share adjustments reflect sponsor alignment and the forfeiture of over-allotment shares. There is no deal progress or extension, but the SPAC is early in its 24-month search window. The filing reaffirms existing redemption mechanics and the absence of any new or adverse sponsor conduct.

What changed: A Schedule 13G beneficial ownership report identifying Meteora Capital, LLC as a reporting shareholder. According to the filing, Meteora Capital, LLC discloses no adjustments to Vendome Acquisition Corp I’s redemption deadline, trust account per-share balance, extension proposal timeline, business combination search progress, or sponsor conduct. The document records only routine institutional holding disclosure. Why it matters: Schedule 13G submissions allow investors to monitor cumulative institutional positioning ahead of special meeting votes or liquidation triggers. While block accumulation can influence shareholder sentiment during redemption windows or extension debates, this filing contains no projections, valuation references, or governance commitments, providing no direct guidance on capital return timing or deal execution.

What changed: Routine compliance exhibit: Exhibit I (Joint Filing Statement) attached to a Schedule 13G beneficial ownership report. The filing establishes that First Trust Merger Arbitrage Fund, First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC will submit the accompanying Schedule 13G as a single coordinated disclosure. By signing, Joy Ausili (Trustee, Vice President, and Assistant Secretary) and Chad Eisenberg (Chief Operating Officer) accept shared responsibility for the timeliness, completeness, and accuracy of the principal statement. Each party acknowledges individual liability for its own portions and limited liability for the others unless it knows or has reason to believe those portions contain inaccuracies. No provisions alter VNME’s redemption window, trust account balance, extension triggers, merger negotiations, or sponsor governance. Why it matters: For investors tracking redemption deadlines, trust value, extension mechanics, deal progress, or sponsor conduct, this document delivers zero operational signal. It is a procedural aggregation tool mandated by Rule 13d-1(k) to streamline filings across affiliated management vehicles. The text contains no claims regarding customer bases, revenue generation, total addressable market, strategic pivots, proprietary technology, partnership agreements, litigation posture, or executive personnel shifts. The only numerical elements are the execution date (November 14, 2025) and the SEC assignment identifier [0001604488-25-000238]. Because it functions exclusively as an administrative liability waiver and filing conduit, it does not require adjustments to redemption calendars, price-per-share trust models, or voting timelines. Its sole market relevance is confirming that all named First Trust affiliates are contractually bound to the same disclosure envelope, eliminating the risk of staggered or conflicting 13G amendments.

What changed: A Schedule 13G/A beneficial ownership report filed on 2025-11-14 identifying Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., Sculptor Master Fund, Ltd., and Sculptor Special Funding, LP as registered holders of Vendome Acquisition Corp I securities. The filing amends a prior Section 13(d) disclosure to reflect the current holding status of the listed Sculptor affiliates. The provided excerpt contains no share quantities, percentage-of-outstanding thresholds, sole or shared voting/investment authority allocations, or comparative historical data. Regarding SPAC mechanics—specifically the documented $10.37 trust-per-share level, the 2027-07-03 business combination deadline, redemption processing, extension feasibility, or sponsor conduct—the document offers no operational updates, cash-commitment figures, merger timelines, or governance motions. No customer relationships, revenue projections, market sizing, technology roadmaps, partnership announcements, litigation developments, or executive appointments are referenced. Why it matters: For investors tracking liquidation windows and trust preservation, this schedule confirms institutional capital remains registered against the IPO vehicle but provides zero actionable data on redemption pacing, extension voting leverage, or deal-execution readiness. Without explicit beneficial-ownership deltas, stated acquisition purposes, or director/sponsor alignment clauses, the filing neither triggers a liquidity event nor alters the projected path toward the 2027-07-03 milestone. Investors must await definitive proxy materials, Form 8-K disclosures of target searches, or shareholder meeting notices to evaluate how this block may influence vote aggregation, tender dynamics, or potential trust-dilution scenarios.

What changed: A Form 12b-25 Notification of Late Filing submitted by Vendome Acquisition Corporation I regarding its quarterly report on Form 10-Q for the period ended September 30, 2025. The registrant disclosed that the Form 10-Q could not meet the prescribed deadline because the Company and its auditor require additional time to complete the final review of the financial statements and disclosures. The company anticipates filing the report no later than the fifth calendar day following the original due date. Chief Executive Officer and Chief Financial Officer Scott LaPorta certified that all periodic reports required under Sections 13, 15(d), and 30 of the governing Acts over the preceding twelve months were filed on schedule, and that no significant change in results of operations is anticipated. The notification was executed on November 14, 2025. Why it matters: As a routine compliance exhibit, this filing does not reset redemption deadlines, modify trust distribution assumptions, or trigger automatic extension mechanics. Nevertheless, temporary filing pauses delay shareholder access to liquidity metrics, trust interest accumulation, and target diligence updates that directly inform redemptions and sponsor strategy. Per LaPorta, no material operational shift is expected, which contains near-term downside risk. SPAC investors should track whether the final auditor review resolves solely around routine closing procedures or uncovers accounting, internal control, or related-party disclosure items that could necessitate future proxy solicitations, cash preservation measures, or sponsor governance adjustments before the seventh month expires.

What changed: Schedule 13G/A (Amended Beneficial Ownership Report) identifying Vendome Acquisition Sponsor I LLC and Vendome Acquisition Holding I LLC as reporting entities. The provided filing text lists two affiliate holders but contains no share quantities, percentage adjustments, acquisition or disposition details, transaction dates, or explanatory narratives. It does not modify the redemption deadline, extend the business combination period, alter trust account mechanics, or announce deal progress. The excerpt contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and includes zero numerical data within the text itself. Why it matters: For investors monitoring redemption calendars, trust valuation, extension mechanisms, and sponsor behavior, this filing represents standard regulatory maintenance rather than a catalyst for capital event timing. While the prompt context notes a $10.37 trust per share and a July 3, 2027 expiration, the 13G/A neither adjusts those parameters nor triggers sponsor fiduciary updates tied to deal execution. Absent revised share counts or control changes, the filing confirms ongoing affiliate disclosure without impacting the path to initial or extended business combination completion.